GLSI GREENWICH LIFESCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, GREENWICH LIFESCIENCES INC reported revenue of n/a, net income of −$3.95M and diluted EPS of −$0.27; for the fiscal year ended December 2025 revenue was n/a.
GLSI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$19.4M, net income −$19.4M (margin n/a), EPS −$1.43
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$17.6M, net income −$17.4M (margin n/a), EPS −$1.34
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$9.33M, net income −$8.89M (margin n/a), EPS −$0.69
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$8.04M, net income −$7.83M (margin n/a), EPS −$0.61
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$4.60M, net income −$4.57M (margin n/a), EPS −$0.35
GLSI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$3.95M, EPS −$0.27
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.66M, EPS −$0.39
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$9.15M, EPS −$0.67
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.71M, EPS −$0.27
- Quarter ended Jun 30, 2025: revenue n/a, net income −$3.75M, EPS −$0.28
- Quarter ended Mar 31, 2025: revenue n/a, net income −$2.74M, EPS −$0.21
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$9.67M, EPS −$0.75
- Quarter ended Sep 30, 2024: revenue n/a, net income −$2.67M, EPS −$0.20
- Quarter ended Jun 30, 2024: revenue n/a, net income −$2.61M, EPS −$0.20
- Quarter ended Mar 31, 2024: revenue n/a, net income −$2.47M, EPS −$0.19
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$2.75M, EPS −$0.20
- Quarter ended Sep 30, 2023: revenue n/a, net income −$2.39M, EPS −$0.19
- Quarter ended Jun 30, 2023: revenue n/a, net income −$1.63M, EPS −$0.13
- Quarter ended Mar 31, 2023: revenue n/a, net income −$2.12M, EPS −$0.17
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$2.79M, EPS n/a
- Quarter ended Sep 30, 2022: revenue n/a, net income −$2.32M, EPS −$0.18
- Quarter ended Jun 30, 2022: revenue n/a, net income −$746K, EPS −$0.06
- Quarter ended Mar 31, 2022: revenue n/a, net income −$1.97M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$2.36M, EPS −$0.17
- Quarter ended Sep 30, 2021: revenue n/a, net income −$863K, EPS −$0.07
GLSI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$9.91M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$7.27M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$6.48M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$6.20M, share buybacks $7.54M
- Fiscal year ended Dec 2021: operating cash flow −$4.29M, share buybacks n/a
GLSI balance sheet
- Jun 30, 2026: cash n/a, total assets $8.88M, total liabilities $5.76M, shareholders' equity $3.12M
- Mar 31, 2026: cash n/a, total assets $10.5M, total liabilities $5.24M, shareholders' equity $5.27M
- Dec 31, 2025: cash $6.18M, total assets $6.18M, total liabilities $5.82M, shareholders' equity $353K
- Sep 30, 2025: cash $3.81M, total assets $3.81M, total liabilities $2.02M, shareholders' equity $2.18M
- Jun 30, 2025: cash $3.13M, total assets $3.13M, total liabilities $2.52M, shareholders' equity $604K
- Mar 31, 2025: cash $2.75M, total assets $2.75M, total liabilities $2.55M, shareholders' equity $200K
- Dec 31, 2024: cash $4.09M, total assets $4.09M, total liabilities $3.19M, shareholders' equity $909K
- Sep 30, 2024: cash $5.82M, total assets $5.83M, total liabilities $842K, shareholders' equity $4.98M
Is GLSI profitable?
No. GREENWICH LIFESCIENCES INC lost $22.5M over the last four quarters.
What is GLSI's EPS?
Diluted earnings per share over the last four quarters were −$1.60; −$0.27 in the latest quarter.